Status: Phase 2
Entry Type: Antibody
Molecule Category: UKNOWN

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Interleukin-13 inhibitor Other

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Hodgkin Disease 1 D006689 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109466